Format

Send to

Choose Destination
Am J Public Health. 2014 Jul;104(7):e108-14. doi: 10.2105/AJPH.2013.301867. Epub 2014 May 15.

Epidemiology and antimicrobial resistance of international travel-associated Campylobacter infections in the United States, 2005-2011.

Author information

1
Emily E. Ricotta, Amanda Palmer, Patricia Ryan, and David Blythe are with the Maryland Department of Health and Mental Hygiene, Baltimore. Katie Wymore is with Public Health Foundation Enterprises, Oakland, CA. Paula Clogher is with the Yale School of Public Health, New Haven, CT. Nadine Oosmanally is with the Georgia Department of Public Health, Atlanta. Trisha Robinson is with the Minnesota Department of Health, St. Paul. Sarah Lathrop is with the University of New Mexico, Alburquerque. Jillian Karr is with the New York State Department of Health, Rochester. Julie Hatch is with the Oregon Health Authority, Public Health Division, Portland. John Dunn is with the Tennessee Department of Health, Nashville.

Abstract

OBJECTIVES:

The objective of this study was to determine the role international travel plays in US Campylobacter epidemiology and antimicrobial resistance.

METHODS:

In this study, epidemiological and antimicrobial resistance data, encompassing the years 2005 to 2011, from 10 sites participating in the Foodborne Diseases Active Surveillance Network were linked. The 10 sites are represented by 7 states that conducted surveillance on a statewide level, and 3 states which conducted county-level surveillance. Cases of Campylobacter among persons with history of international travel in the week prior to illness were compared with cases among individuals with no international travel.

RESULTS:

Approximately 18% of Campylobacter infections were estimated to be associated with international travel, and 60% of international travel-associated infections had a quinolone-resistant Campylobacter isolate.

CONCLUSIONS:

We confirm that international travel plays a significant role in campylobacteriosis diagnosed in the United States. Recognizing this is important to both medical management decisions and understanding burden and attribution estimates of US campylobacteriosis and antibiotic-resistant campylobacteriosis.

PMID:
24832415
PMCID:
PMC4056211
DOI:
10.2105/AJPH.2013.301867
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center